Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia | |
Qin, Shukui; Bai, Yuxian; Lim, Ho Yeong; Thongprasert, Sumitra; Chao, Yee; Fan, Jia; Yang, Tsai-Shen; Bhudhisawasdi, Vajarabhongsa; Kang, Won Ki; Zhou, Yu | |
刊名 | JOURNAL OF CLINICAL ONCOLOGY |
2013 | |
卷号 | 31期号:28 |
ISSN号 | 0732-183X |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4901485 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Qin, Shukui,Bai, Yuxian,Lim, Ho Yeong,et al. Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia[J]. JOURNAL OF CLINICAL ONCOLOGY,2013,31(28). |
APA | Qin, Shukui.,Bai, Yuxian.,Lim, Ho Yeong.,Thongprasert, Sumitra.,Chao, Yee.,...&Sun, Yan.(2013).Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia.JOURNAL OF CLINICAL ONCOLOGY,31(28). |
MLA | Qin, Shukui,et al."Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia".JOURNAL OF CLINICAL ONCOLOGY 31.28(2013). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论